06 Oct 2025 | 3 Mins Read
Pharma stock rises 5% on Zuventus Healthcare acquisition
Flipitmoney
Emcure Pharmaceuticals surged nearly 5% after acquiring the remaining 20.42% stake in Zuventus Healthcare, making it a wholly-owned subsidiary, as investors reacted positively to the strategic acquisition. The company now fully controls Zuventus and this move reflects confidence in Emcure's business.